Elevated level of membrane microparticles in the disease of steroid-induced vascular osteonecrosis

Journal of Craniofacial Surgery

Volumn 24, Issue 4, 2013, Pages 1252-1256

  Wu, Zhihong ^a   Ji, Chunliang ^a   Li, Hui ^a   Qiu, Guixing ^a   Gao, Cunji ^b   Weng, Xisheng ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

coagulation; membrane microparticles; Osteonecrosis

Indexed keywords

METHYLPREDNISOLONE;

ANIMAL; BONE NECROSIS; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; FEMALE; FEMUR HEAD NECROSIS; FLOW CYTOMETRY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MEMBRANE MICROPARTICLE; PATHOLOGY; RABBIT;

ANIMALS; CELL-DERIVED MICROPARTICLES; DISEASE MODELS, ANIMAL; FEMALE; FEMUR HEAD NECROSIS; FLOW CYTOMETRY; INJECTIONS, INTRAMUSCULAR; MALE; METHYLPREDNISOLONE; OSTEONECROSIS; RABBITS;

EID: 84880898246     PISSN: 10492275     EISSN: 15363732     Source Type: Journal    
DOI: 10.1097/SCS.0b013e3182902dd3     Document Type: Article

References (33)

1. Mankin HJ. Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 1992;326:1473-1479
2. Chang JK, Ho ML, Yeh CH, et al. Osteogenic gene expression decreases in stromal cells of patients with osteonecrosis. Clin Orthop Relat Res 2006;453:286-292
3. Jones LC, Hungerford DS. The pathogenesis of osteonecrosis. Instr Course Lect 2007;56:179-196
4. Johannson HR, Zywiel MG, Marker DR, et al. Osteonecrosis is not a predictor of poor outcomes in primary total hip arthroplasty: a systematic literature review. Int Orthop 2011;35:465-473
5. Weil LS Jr, Roukis TS, Weil LS, et al. Extracorporeal shock wave therapy for the treatment of chronic plantar fasciitis: indications, protocol, intermediate results, and a comparison of results to fasciotomy. J Foot Ankle Surg 2002;41:166-172
6. Gebhard KL, Maibach HI. Relationship between systemic corticosteroids and osteonecrosis. Am J Clin Dermatol 2001;2:377-388
7. Weinstein RS, Nicholas RW, Manolagas SC. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab 2000;85:2907-2912
8. Kerachian MA, Harvey EJ, Cournoyer D, et al. Avascular necrosis of the femoral head: vascular hypotheses. Endothelium 2006;13:237-244
9. Bejar J, Peled E, Boss JH. Vasculature deprivationYinduced osteonecrosis of the rat femoral head as a model for therapeutic trials. Theor Biol Med Model 2005;2:24
10. Whitworth JA, Brown MA, Kelly JJ, et al. Mechanisms of cortisol-induced hypertension in humans. Steroids 1995;60:76-80
11. Hugel B, Martinez MC, Kunzelmann C, et al. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 2005;20:22-27
12. Roos MA, Gennero L, Denysenko T, et al. Microparticles in physiological and in pathological conditions. Cell Biochem Funct 2010;28:539-548
13. Boulanger CM. Microparticles, vascular function and hypertension. Curr Opin Nephrol Hypertens 2010;19:177-180
14. Kim HK, Song KS, Park YS, et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 2003;39:184-191
15. Mobarrez F, Antovic J, Egberg N, et al. A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thrombosis research 2010;125:e110-e116
16. Gasser O, Schifferli JA. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood 2004;104:2543-2548
17. Biro E, Sturk-Maquelin KN, Vogel GM, et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003;1: 2561-2568
18. Chou J, Mackman N, Merrill-Skoloff G, et al. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004;104:3190-3197
19. Hoffman M, Monroe DM, Roberts HR. Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: a flow cytometric study. Thromb Haemost 1992;68:74-78
20. Owens MR. The role of platelet microparticles in hemostasis. Transfus Med Rev 1994;8:37-44
21. Horstman LL, Ahn YS. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 1999;30:111-142
22. Freyssinet JM. Cellular microparticles: what are they bad or good for? J Thromb Haemost 2003;1:1655-1662
23. Horstman LL, Jy W, Jimenez JJ, et al. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004;9:1118-1135
24. Morel O, Toti F, Hugel B, et al. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 2004;11:156-164
25. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006;20:1-26
26. Yang YL, Liu WJ. [Research progress of platelet proteomicsVreview]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012;20:777-781
27. Camus SM, Gausseres B, Bonnin P, et al. Erythrocyte microparticles can induce kidney vaso-occlusions in a murine model of sickle cell disease. Blood 2012
28. Freyssinet JM, Toti F. Membrane microparticle determination: at least seeing what's being sized! J Thromb Haemost 2010;8:311-314
29. Brodsky SV, Satoskar A, Nadasdy T. Endothelial microparticles in transplant patientsVgreat potential but a long way to go. Front Biosci (Elite Ed) 2012;4:876-888
30. Boilard E, Nigrovic PA, Larabee K, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010;327:580-583
31. Thom SR, Milovanova TN, Bogush M, et al. Microparticle production, neutrophil activation, and intravascular bubbles following open-water SCUBA diving. J Appl Physiol 2012;112: 1268-1278
32. Gao C, Xie R, Yu C, et al. Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome. Thromb Haemost 2012;107:681-689
33. Zwicker JI, Trenor CC 3rd, Furie BC, et al. Tissue factor-bearing microparticles and thrombus formation. Arterioscler Thromb Vasc Biol 2011;31:728-733